Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone undecanoate in men with cirrhosis and low testosterone
ACTRN12616000756426Phase 4Not yet recruiting
- Sponsor
- Austin Hospital
- Start
- Apr 2017
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Cirrhosis and Hypoandrogenism (TD) comparing Testosterone undecanoate with Placebo (2 arms). Primary endpoint: Composite of mortality or major infection requiring hospitalization. Planned start Apr 2017; status: not yet recruiting.
02
Drugs
testosterone undecanoate
03
Conditions
CirrhosisHypoandrogenism (TD)
Beyond the preview
Go deeper on ACTRN12616000756426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000756426.